Financials

  • Market Capitalization 118.4 M
  • Employee 4
  • Founded 1982
  • CEO N/A
  • Website www.anixa.com
  • Headquarter Delaware, United States
  • FIGI BBG000BG3J79
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-12.15
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3856
PMN
ProMIS Neurosciences Inc. - Common Shares
13.47 USD-3.72%-6.13%-3.51%+2394.44%120.79 M USD
3860
GNLX
Genelux Corporation - Common Stock
2.66 USD-7.64%-1.48%-7.96%-19.39%120.35 M USD
3874
RANI
Rani Therapeutics Holdings, Inc. - Class A Common Stock
0.84 USD-1.18%-5.62%-1.18%+68.00%117.09 M USD
3884
NAUT
Nautilus Biotechnology, Inc. - Common Stock
0.89 USD-1.11%-8.25%-14.42%+30.88%113.26 M USD

Notizie